Stephen P. Carey's most recent trade in ANI Pharmaceuticals Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 50,000 | 0 | - | - | Stock Option (right to buy) | |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Sale of securities on an exchange or to another person at price $ 86.07 per share. | 12 Aug 2025 | 50,000 | 180,863 (1%) | 0% | 86.1 | 4,303,500 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.49 per share. | 12 Aug 2025 | 50,000 | 230,863 (1%) | 0% | 46.5 | 2,324,500 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.26 per share. | 23 Mar 2025 | 6,210 | 180,863 (1%) | 0% | 64.3 | 399,055 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.62 per share. | 07 Mar 2025 | 5,150 | 187,073 (1%) | 0% | 60.6 | 312,193 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.89 per share. | 28 Feb 2025 | 1,861 | 192,223 (1%) | 0% | 61.9 | 115,177 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,808 | 179,276 (1%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 16,538 | 195,814 (1%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.92 per share. | 12 Feb 2025 | 1,730 | 194,084 (1%) | 0% | 58.9 | 101,932 | Common Stock |
| ANI Pharmaceuticals Inc | Carey Stephen P. | SVP & CFO | Sale of securities on an exchange or to another person at price $ 55.79 per share. | 17 Dec 2024 | 7,500 | 154,468 (1%) | 0% | 55.8 | 418,425 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Sale of securities on an exchange or to another person at price $ 63.58 per share. | 04 Jun 2024 | 5,000 | 161,968 (1%) | 0% | 63.6 | 317,900 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.96 per share. | 10 Apr 2024 | 4,534 | 166,968 (1%) | 0% | 67.0 | 303,597 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.58 per share. | 23 Mar 2024 | 6,210 | 171,502 (1%) | 0% | 69.6 | 432,092 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Sale of securities on an exchange or to another person at price $ 65.55 per share. | 07 Mar 2024 | 7,787 | 177,712 (1%) | 0% | 65.6 | 510,438 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.71 per share. | 07 Mar 2024 | 4,216 | 185,499 (1%) | 0% | 66.7 | 281,249 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,914 | 189,715 (1%) | 0% | 67.7 | 129,520 | Common Stock |
| ANI Pharmaceuticals Inc | Carey Stephen P. | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 21,474 | 177,313 (1%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Carey Stephen P. | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,316 | 191,629 (1%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Sale of securities on an exchange or to another person at price $ 61.37 per share. | 14 Aug 2023 | 17,639 | 155,839 (1%) | 0% | 61.4 | 1,082,505 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.50 per share. | 10 Apr 2023 | 4,534 | 173,478 (1%) | 0% | 38.5 | 174,559 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.62 per share. | 28 Mar 2023 | 1,420 | 137,486 (1%) | 0% | 38.6 | 54,840 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.82 per share. | 23 Mar 2023 | 4,224 | 138,906 (1%) | 0% | 37.8 | 159,752 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 2,639 | 143,994 (1%) | 0% | 44.2 | 116,723 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.23 per share. | 07 Mar 2023 | 864 | 143,130 (1%) | 0% | 44.2 | 38,215 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 24,316 | 161,802 (1%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 16,210 | 178,012 (1%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 11,291 | 146,633 (1%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.91 per share. | 10 Apr 2022 | 4,534 | 135,342 (1%) | 0% | 29.9 | 135,612 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.69 per share. | 06 Apr 2022 | 912 | 139,876 (1%) | 0% | 29.7 | 27,077 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.17 per share. | 28 Mar 2022 | 1,420 | 140,788 (1%) | 0% | 28.2 | 40,001 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 33,875 | 142,208 (1%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.86 per share. | 12 Apr 2021 | 3,042 | 112,500 (0%) | 0% | 31.9 | 96,918 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.69 per share. | 06 Apr 2021 | 612 | 115,542 (0%) | 0% | 33.7 | 20,618 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.68 per share. | 29 Mar 2021 | 953 | 116,662 (0%) | 0% | 32.7 | 31,144 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.14 per share. | 29 Mar 2021 | 508 | 116,154 (0%) | 0% | 36.1 | 18,359 | Common Stock |
| ANI Pharmaceuticals Inc | Stephen P. Carey | SENIOR VICE PRESIDENT AND CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2021 | 54,470 | 117,615 (0%) | 0% | 0 | Common Stock |